Connections in the brain involved in epileptic seizures identified
Researchers at UCL have discovered a network of connections in the brain linked to seizures in people with epilepsy.
BRC News
Scientists closer to understanding the devastating loss of fat and muscle during cancer
Scientists examining the causes of cachexia believe they are now one step closer to understanding the causes behind the condition.
How air pollution can cause lung cancer in people who have never smoked
Research supported by the BRC has revealed how air pollution can cause lung cancer in people who have never smoked.
World-first MS mega-trial opens
A world-first trial for people living with progressive forms of multiple sclerosis (MS) has begun at UCL and UCLH.
Dementia research careers service at UCLH and UCL secures £1.1 million
A leading platform for dementia research careers and support has secured £1.1 million in funding for five years.
Research autopsies reveal how incurable skin cancer resists treatment
Research has discovered how some skin cancers stop responding to treatment at the end of life.
Spotlight on future of UCLH and UCL research at BRC launch event
An event to mark the launch of a new BRC term looked ahead to the future of research at UCLH and UCL.
UCL ranked 6th globally for medicine in world rankings
UCL has been placed 6th globally for medicine and 1st for education in the world’s most consulted university ranking.
Preterm babies do not habituate to repeated pain
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, a study led by UCL has found.
Population-wide risk scores limited ability to predict disease
Predictive performance of polygenic risk scores is limited, according to a new analysis
UCLH and Crick research influence new national treatment guidelines for COVID-19
Research from UCLH and the Francis Crick Institute has had an important impact on draft NICE guidance.
Flagship NIHR career development award for BRC research leader
Prof Laura Shallcross will lead research to reduce the impact of infections in care homes after being awarded a prestigious NIHR Research Professorship.
UCLH patient first in world to receive a new investigational drug in a phase 1 trial
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
Wearable tech, AI and clinical teams combine to change the face of clinical trial monitoring
A multi-disciplinary team of researchers, involving several UCLH and UCL clinicians and scientists, has developed a way to monitor the progression of movement disorders using motion capture technology and AI.
New precision therapy for bile duct cancer extends patients’ lives
A new personalised cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international multicentre trial involving researchers at UCL and UCLH.
